CEFIZOX IN PLASTIC CONTAINER Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Cefizox In Plastic Container, and when can generic versions of Cefizox In Plastic Container launch?
Cefizox In Plastic Container is a drug marketed by Astellas and is included in one NDA.
The generic ingredient in CEFIZOX IN PLASTIC CONTAINER is ceftizoxime sodium. There are five drug master file entries for this compound. Additional details are available on the ceftizoxime sodium profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CEFIZOX IN PLASTIC CONTAINER?
- What are the global sales for CEFIZOX IN PLASTIC CONTAINER?
- What is Average Wholesale Price for CEFIZOX IN PLASTIC CONTAINER?
Summary for CEFIZOX IN PLASTIC CONTAINER
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 29 |
Clinical Trials: | 1 |
Patent Applications: | 853 |
DailyMed Link: | CEFIZOX IN PLASTIC CONTAINER at DailyMed |
Recent Clinical Trials for CEFIZOX IN PLASTIC CONTAINER
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Ministry of Health, Sudan | Phase 4 |
University of Khartoum | Phase 4 |
US Patents and Regulatory Information for CEFIZOX IN PLASTIC CONTAINER
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Astellas | CEFIZOX IN PLASTIC CONTAINER | ceftizoxime sodium | INJECTABLE;INJECTION | 050589-003 | Apr 13, 1995 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
Astellas | CEFIZOX IN PLASTIC CONTAINER | ceftizoxime sodium | INJECTABLE;INJECTION | 050589-004 | Apr 13, 1995 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |